Identification of a leukemic counterpart of the plasmacytoid dendritic cells, Blood, vol.97, issue.10, pp.3210-3217, 2001. ,
DOI : 10.1182/blood.V97.10.3210
World Health Organisation Classification of Tumors, 2008. ,
Blastic plasmacytoid dendritic cell neoplasm in children: diagnostic features and clinical implications, Haematologica, vol.95, issue.11, pp.1873-1879, 2010. ,
DOI : 10.3324/haematol.2010.026179
URL : http://doi.org/10.3324/haematol.2010.026179
Usefulness of allogeneic hematopoietic stem cell transplantation in first complete remission for pediatric blastic plasmacytoid dendritic cell neoplasm with skin involvement: A case report and review of literature, Pediatric Blood & Cancer, vol.36, issue.11, pp.140-142, 2013. ,
DOI : 10.1002/pbc.24622
Blastic plasmacytoid dendritic cell neoplasm: clinical features in 90 patients, British Journal of Dermatology, vol.118, issue.3, pp.579-586, 2013. ,
DOI : 10.1111/bjd.12412
TCL1 and CLA Expression in Agranular CD4/CD56 Hematodermic Neoplasms (Blastic NK-Cell Lymphomas) and Leukemia Cutis, American Journal of Clinical Pathology, vol.122, issue.2 ,
DOI : 10.1309/0QPPAVTUPCV9UCLV
Intracytoplasmic detection of TCL1-but not ILT7-by flow cytometry is useful for blastic plasmacytoid dendritic cell leukemia diagnosis, Cytometry Part A, vol.66, issue.8, pp.718-724, 2012. ,
DOI : 10.1002/cyto.a.22072
URL : https://hal.archives-ouvertes.fr/inserm-00718156
Extended diagnostic criteria for plasmacytoid dendritic cell leukaemia, British Journal of Haematology, vol.75, issue.5, pp.624-636, 2009. ,
DOI : 10.1111/j.1365-2141.2009.07679.x
URL : https://hal.archives-ouvertes.fr/hal-00451257
Novel markers of normal and neoplastic human plasmacytoid dendritic cells, Blood, vol.111, issue.7, pp.3778-3792, 2008. ,
DOI : 10.1182/blood-2007-10-117531
Blastic NK-Cell Lymphomas (Agranular CD4+CD56+ Hematodermic Neoplasms), American Journal of Clinical Pathology, vol.123, issue.5, pp.662-675, 2005. ,
DOI : 10.1309/GJWNPD8HU5MAJ837
Blastic plasmacytoid dendritic cell neoplasm: is transplantation the treatment of choice?, British Journal of Dermatology, vol.91, issue.1, pp.74-79, 2009. ,
DOI : 10.1111/j.1365-2133.2009.09373.x
Blastic Plasmacytoid Dendritic Cell Neoplasia (BPDC) in Elderly Patients: Results of a Treatment Algorithm Employing Allogeneic Stem Cell Transplantation with Moderately Reduced Conditioning Intensity, Biology of Blood and Marrow Transplantation, vol.17, issue.8, pp.1250-1254, 2011. ,
DOI : 10.1016/j.bbmt.2010.12.706
Stem cell transplantation can provide durable disease control in blastic plasmacytoid dendritic cell neoplasm: a retrospective study from the European Group for Blood and Marrow Transplantation, Blood, vol.121, issue.3, pp.440-446, 2013. ,
DOI : 10.1182/blood-2012-08-448613
Sequential combination of high dose methotrexate and L-asparaginase followed by allogeneic transplant: a first-line strategy for CD4+ ,
Blastic plasmacytoid dendritic cell neoplasm with leukemic presentation: an Italian multicenter study, Haematologica, vol.98, issue.2, pp.239-246, 2013. ,
DOI : 10.3324/haematol.2012.072645
Blastic plasmacytoid dendritic cell neoplasm: is it time to redefine the standard of care?, Expert Review of Hematology, vol.5, issue.4, pp.353-355, 2012. ,
DOI : 10.1586/ehm.12.33
A combination treatment approach and cord blood stem cell transplant for blastic plasmacytoid dendritic cell neoplasm, Haematologica, vol.98, issue.3, p.36, 2013. ,
DOI : 10.3324/haematol.2012.080051
Signal transduction, cell cycle regulatory, and anti-apoptotic pathways regulated by IL-3 in hematopoietic cells: possible sites for intervention with anti-neoplastic drugs, Leukemia, vol.13, issue.8, pp.1109-1166, 1999. ,
DOI : 10.1038/sj.leu.2401493
Cytokine Receptors and Signal Transduction, Annual Review of Immunology, vol.10, issue.1, pp.295-331, 1992. ,
DOI : 10.1146/annurev.iy.10.040192.001455
Characterization of diphtheria fusion proteins targeted to the human interleukin-3 receptor, Protein Engineering Design and Selection, vol.13, issue.8, pp.575-581, 2000. ,
DOI : 10.1093/protein/13.8.575
Mutational analysis of the alpha subunit of the human interleukin-3 receptor, Blood, vol.87, issue.1, pp.112-122, 1996. ,
Recombinant immunotoxins containing truncated bacterial toxins for the treatment of hematologic malignancies Phase I clinical study of diphtheria toxininterleukin 3 fusion protein in patients with acute myeloid leukemia and myelodysplasia, BioDrugs. Leuk Lymphoma, vol.2349, issue.233, pp.1-13543, 2008. ,
Activity of SL-401, a targeted therapy directed to interleukin-3 receptor, in blastic plasmacytoid dendritic cell neoplasm patients, Blood, vol.124, issue.3, pp.385-392, 2014. ,
DOI : 10.1182/blood-2014-04-566737
A singleplatform approach using flow cytometry and microbeads to evaluate immune reconstitution in mice after bone marrow trans- plantation ,
Diphtheria toxin fused to human interleukin-3 is toxic to blasts from patients with myeloid leukemias, Leukemia, vol.14, issue.4, pp.576-585, 2000. ,
DOI : 10.1038/sj.leu.2401743
Diphtheria toxin-interleukin-3 fusion protein (DT388IL3) prolongs disease-free survival of leukemic immunocompromised mice, Leukemia, vol.17, issue.1, pp.155-159, 2003. ,
DOI : 10.1038/sj.leu.2402744
A diphtheria toxin-interleukin 3 fusion protein is cytotoxic to primitive acute myeloid leukemia progenitors but spares normal progenitors, Cancer Res, vol.62, issue.6, pp.1730-1736, 2002. ,
High affinity interleukin-3 receptor expression on blasts from patients with acute myelogenous leukemia correlates with cytotoxicity of a diphtheria toxin/IL-3 fusion protein, Leukemia Research, vol.25, issue.10, pp.875-881, 2001. ,
DOI : 10.1016/S0145-2126(01)00034-0
Variant Diphtheria Toxin-Interleukin-3 Fusion Proteins with Increased Receptor Affinity Have Enhanced Cytotoxicity against Acute Myeloid Leukemia Progenitors, Clinical Cancer Research, vol.12, issue.4, pp.1284-1291, 2006. ,
DOI : 10.1158/1078-0432.CCR-05-2070
Characterization of variant diphtheria toxin???interleukin-3 fusion protein, DTIL3K116W, for phase I clinical trials, Biologicals, vol.38, issue.1, pp.144-149, 2010. ,
DOI : 10.1016/j.biologicals.2009.08.016
The IL-3Ra-targeted drug SL-401 selectively kills blastic plasmacytoid dendritic cell neoplasm cells, Blood, vol.118, p.2588, 2011. ,
The Enigmatic Plasmacytoid T Cells Develop into Dendritic Cells with Interleukin (IL)-3 and CD40-Ligand, The Journal of Experimental Medicine, vol.153, issue.6, pp.1101-1111, 1997. ,
DOI : 10.1084/jem.185.2.341
Successful Non-Myeloablative Allogeneic HLA-Identical Stem Cell Transplantation for CD4/CD56 Positive Acute Leukemia, Transplantation, vol.84, issue.8, pp.1066-1067, 2007. ,
DOI : 10.1097/01.tp.0000286098.28481.7d
Haematodermic CD4+CD56+ neoplasm: complete remission after methotrexate-asparaginase treatment, Clinical and Experimental Dermatology, vol.58, issue.5, pp.43-45, 2009. ,
DOI : 10.1111/j.1365-2230.2008.03100.x
L-asparaginase with methotrexate and dexamethasone is an effective treatment combination in blastic plasmacytoid dendritic cell neoplasm, British Journal of Haematology, vol.34, issue.4, pp.543-545, 2013. ,
DOI : 10.1111/bjh.12523
CD4+ CD56+ hematodermic/plasmacytoid dendritic cell tumor with response to pralatrexate, Journal of the American Academy of Dermatology, vol.58, issue.3, pp.480-484, 2008. ,
DOI : 10.1016/j.jaad.2007.12.012
Plasmacytoid Dendritic Cell Leukemia with Potent Antigen-Presenting Ability, Acta Haematologica, vol.120, issue.2, pp.91-99, 2008. ,
DOI : 10.1159/000165510
Therapeutic Effect of Lenalidomide in a Novel Xenograft Mouse Model of Human Blastic NK Cell Lymphoma/Blastic Plasmacytoid Dendritic Cell Neoplasm, Clinical Cancer Research, vol.17, issue.19, pp.6163-6173, 2011. ,
DOI : 10.1158/1078-0432.CCR-11-0212
Exome sequencing reveals novel and recurrent mutations with clinical impact in blastic plasmacytoid dendritic cell neoplasm, Leukemia, vol.10, issue.4, pp.823-829, 2014. ,
DOI : 10.1038/nrd3943
Molecular profiling of blastic plasmacytoid dendritic cell neoplasm reveals a unique pattern and suggests selective sensitivity to NF-kB pathway inhibition, Leukemia, vol.406, issue.8, pp.1606-1616, 2014. ,
DOI : 10.1200/JCO.2012.42.5611
An immunotoxin for the treatment of T-acute lymphoblastic leukemic meningitis: studies in rhesus monkeys, Cancer Immunology Immunotherapy, vol.28, issue.1, pp.59-66, 1989. ,
DOI : 10.1007/BF00205802